The European and Developing Countries Clinical Trials Partnership (EDCTP) programme is set to enter into its second phase, accelerating the development of new or improved drugs, vaccines, microbicides and diagnostics against poverty-related diseases – in particular for HIV/AIDS, tuberculosis and malaria, diseases which accounted for over 3.5 million deaths in 2012.